Production of two recombinant insulin-like growth factor binding protein-1 subtypes specific to salmonids

•Two recombinant IGFBP-1 subtypes specific to salmonids were produced.•Effects of four salmon IGFBP-1 subtypes on GH release were examined.•IGFBP-1 subtypes inhibited the GH-suppressive effect of IGF-I. Salmonids have four subtypes of insulin-like growth factor binding protein (IGFBP)-1, termed -1a1...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:General and comparative endocrinology 2020-12, Vol.299, p.113606-113606, Article 113606
Hauptverfasser: Hasegawa, Ryuya, Miura, Takuto, Kaneko, Nobuto, Kizaki, Ryousuke, Oishi, Gakuto, Tanaka, Hanae, Sato, Moe, Shimizu, Munetaka
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Two recombinant IGFBP-1 subtypes specific to salmonids were produced.•Effects of four salmon IGFBP-1 subtypes on GH release were examined.•IGFBP-1 subtypes inhibited the GH-suppressive effect of IGF-I. Salmonids have four subtypes of insulin-like growth factor binding protein (IGFBP)-1, termed -1a1, -1a2, -1b1 and 1b2, owing to teleost- and a lineage-specific whole-genome duplications. We have previously produced recombinant proteins of masu salmon IGFBP-1a1 and -1b2 and conducted functional analysis. To further characterize salmonid-specific IGFBP-1s, we cloned cDNAs encoding mature proteins of IGFBP-1a2 and -1b1 from the liver of masu salmon (Oncorhynchus masou). IGFBP-1a2 and -1b1 shared a 56% amino acid sequence homology whereas their homologies with their counterparts (i.e. -1a1 and -1b2) were 77% and 82%, respectively. We next expressed recombinant masu salmon (rs) IGFBP-1a2 and -1b1 with fusion partners thioredoxin (Trx) and a His-tag using the pET-32a(+) vector system in Escherichia coli. Trx.His.rsIGFBP-1s were detected in the insoluble faction, solubilized in a buffer containing urea, and isolated by Ni-affinity chromatography. They were refolded by dialysis and cleaved from the fusion partners by enterokinase. rsIGFBP-1a2 and -1b1 were purified by reversed-phase high performance liquid chromatography. Purified rsIGFBP-1a2 and -1b1 had the ability to bind digoxigenin-labeled human IGF-I on ligand blotting. We then examined the effects of rsIGFBP-1a1, -1a2, -1b1 and -1b2 in combination with human IGF-I on growth hormone (GH) release from cultured pituitary cells of masu salmon. IGF-I alone reduced GH release while the addition of rsIGFBP-1a1, -1b1 or -1b2, but not rsIGFBP-1a2, diminished the suppressive effect of IGF-I. Addition of rsIGFBP-1s without IGF-I had no effect on GH release. These results show that rsIGFBP-1b1, along with rsIGFBP-1a1 and -1b2, inhibits IGF-I action on the pituitary in masu salmon. The lack of the effect by rsIGFBP-1a2 suggests that salmon IGFBP-1 subtypes underwent subfunction partitioning and have different degrees of IGF-inhibitory action.
ISSN:0016-6480
1095-6840
DOI:10.1016/j.ygcen.2020.113606